4582 — SymBio Pharmaceuticals Share News
0.000.00%
Table: SymBio Pharmaceuticals - 9-MTH parent results
Table: SymBio Pharmaceuticals - 6-MTH parent results
Table: SymBio Pharmaceuticals - Q1 parent results
Australia's Superloop eyes best day in nearly 3 months on contract win
Table: SymBio Pharmaceuticals -2020 parent results
Table: SymBio Pharmaceuticals - 9-MTH parent results
Table: SymBio Pharmaceuticals -2020 parent forecast
Table: SymBio Pharmaceuticals - 6-MTH parent results
Table: SymBio Pharmaceuticals - Q1 parent results
Table: SymBio Pharmaceuticals -2019 parent results
Table: SymBio Pharmaceuticals - 9-MTH parent results
Brief: Chimerix Announces Exclusive Global License Agreement With Symbio Pharma For Brincidofovir
Table: SymBio Pharmaceuticals - 6-MTH parent results
Table: SymBio Pharmaceuticals - Q1 parent results
Table: SymBio Pharmaceuticals -2018 parent results
Table: SymBio Pharmaceuticals - 9-MTH parent results
Brief: SymBio Pharmaceuticals says exercise of options
Brief: SymBio Pharmaceuticals says exercise of options
Brief: SymBio Pharmaceuticals says exercise of options